Published by Miramax 0001-01-01 00:00:00
Seller: R Bookmark, Youngtown, AZ, U.S.A.
dvd. Condition: Used - Good.
US$ 10.30
Quantity: 2 available
Add to baskethardcover. Condition: New. Next day dispatch (mon-fri). Please note orders sent to Netherlands or Sweden take slightly longer than the Amazon estimated delivery date. Same day/next day dispatch (mon-fri) all items checked before dispatch, Handled and sent out with care.
US$ 15.32
Quantity: 12 available
Add to basketHardcover. Condition: New.
Hardcover. Condition: New. US SELLER SHIPS FAST FROM USA.
US$ 24.16
Quantity: 1 available
Add to basketHardcover. Condition: Brand New. 1st edition. 296 pages. 9.75x7.50x0.75 inches. In Stock.
Language: English
Published by Martin Dunitz Ltd, London, 2002
ISBN 10: 190186572X ISBN 13: 9781901865721
Seller: PsychoBabel & Skoob Books, Didcot, United Kingdom
US$ 32.95
Quantity: 1 available
Add to basketHardcover. Condition: Very Good. Dust Jacket Condition: No Dust Jacket. This text reviews the latest ideas in tumor biology, explains the pharmacologic basis of the agents used, and discusses how they are applied in clinical practice. Part One presents an overview of the clinical importance of endocrine therapy, and describes the applications of the principal classes of drugs, including antiestrogens, aromatase inhibitors, progestins, and progesterone receptor antagonists. This section also discusses ovarian ablation. Part Two deals with the biological aspects of endocrine therapies, and relates current understanding of tumor biology and the pharmacologic basis of hormonal agents to their clinical applications. Among the topics covered are resistance and sensitivity to therapy. Part Three outlines future strategies, in particular the use of combination endocrine therapy, adjuvant growth factor therapy and the use of anti-invasive agents. This text is essential for oncologists and pharmacologists alike. Clean Copy.
Published by Ambit, 1998
Seller: Shore Books, London, United Kingdom
Magazine / Periodical
US$ 27.59
Quantity: 1 available
Add to basketSoft cover. Condition: Very Good. 96 pages. Ralph Steadman " Vital Reading of the 20th Century". 2 Peter Porter Sassetta Sequence Mike Foreman Drawings 9 Ron Sandford and Peter Porter Art into Ambit 15 Ron Sandford / Judy Gahagan Fruit: Pearl River Delta 22 Pascale Petit Poems 25 Sarah Raphael Strip! 31 E.A. Markham Horace: A Wonder of the World Part II 40 John Welch Poems 43 Ralph Steadman Vital Reading of the 20th Century 50 Ken Cox / Julie Charalambides Flesh & Stones 62 Robert McAulay/ Martin Bax Bible Story 69 David Winwood Poems 70 Laura Knight / Jacqueline Lucas Not a Full Deck 76 Charles Shearer / Alan Brownjohn Irish Castles 79 Scannell / Srivastava Reviews 84 Diana Hendry Poems 86 David Remfry / Geoff Nicholson Lori: A New York Story 94 Peter Werner Poems 96 Ron Sandford Portrait of Judy Gahagan Artwork on cover by Ralph Steadman.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Published by W. F. Prior Company, Inc., Hagerstown, Maryland, USA, 1952
Seller: The Old Sage Bookshop, Prescott, AZ, U.S.A.
Hardcover. Condition: Very Good+. No Jacket. Cloth hardcover made to resemble leather; black spine with gilt lettering; gray boards; each chapter separately paginated; b&w illustrations. Very good plus condition: very slight wear. Will cost extra for shipping. Size: 4to - over 9¾ - 12" tall. Book.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Language: English
Published by Taylor & Francis Group, 2002
ISBN 10: 190186572X ISBN 13: 9781901865721
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 296 1st Edition.
Language: English
Published by Taylor & Francis Group, 2002
ISBN 10: 190186572X ISBN 13: 9781901865721
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 296.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 161.90
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New.
Seller: UK BOOKS STORE, London, LONDO, United Kingdom
US$ 195.63
Quantity: Over 20 available
Add to basketCondition: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 190.16
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 193.81
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 230 pages. 9.25x6.25x1.00 inches. In Stock.
Condition: New.
Condition: As New. Unread book in perfect condition.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 212.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 212.
Language: English
Published by Springer Netherlands, Springer Netherlands, 2010
ISBN 10: 9048179017 ISBN 13: 9789048179015
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.
Language: English
Published by Springer Netherlands, 2009
ISBN 10: 1402085257 ISBN 13: 9781402085253
Seller: Buchpark, Trebbin, Germany
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens. Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - One of the main causes of failure in the treatment of breast cancer is the intrinsic presence of, or development of, drug resistance by the cancer cells. Recent studies on the mechanisms of cancer drug resistance have yielded important information highlighting both how tumour cells may escape these therapeutic constraints and that drug resistance may further impinge on tumour cell functions that may ultimately promote an adverse cell phenotype. New targets have been identified with potential therapeutic applications in resistant breast cancer leading to the subsequent evaluation of inhibitors of these targets in preclinical studies. Importantly, there is increasing evidence from such studies demonstrating the benefit of novel combination strategies as potential avenues for future drug regimens.Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.